May 23, 2011 -- It's earnings season, and almost every day for the past few weeks, one to three China life science companies listed in the US have released their quarterly financial reports. Taken as a whole, companies from this sector have almost uniformly reported higher revenues. Net income has also risen, though usually not as much. Price/Earnings ratios are lower than they were a few years ago, ranging from 31 down to a lowly 1.4. We give snapshots of the sixteen companies that have released reports so far this month. More details....
